BWX Technologies
BWXT NYSE Aerospace & Defense Financials FY2016βFY2025
BWX Technologies' revenue rose 18.3% to $3.2 billion in fiscal 2025. Its operating margin was 12.7%, down from 14.1% a year earlier. Free cash flow was $295 million, up 15.9%. It paid out $122 million in dividends and buybacks, 41% of free cash flow.
What BWX Technologies does
No business description yet.
- Legal name
- BWX TECHNOLOGIES, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001486957-26-000007
0001486957
Revenue and margins
BWX Technologies had $3.2B of revenue in fiscal 2025, up 18.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 8.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $295M in fiscal 2025, 9.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
BWX Technologies returned $122M to shareholders in fiscal 2025, 41% of free cash flow. The diluted share count rose 0.0%.
Value BWX Technologies yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.5B and divides by 91.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 33.0x Β· peers 39.0x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably BWX Technologies can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $37.7M | $39.0M | $75.8M | $74.1M | $500M |
| Debt incl. finance leases | $1.2B | $1.3B | $1.2B | $1.1B | $2.0B |
| Net debt / EBITDA | 2.8x | 3.0x | 2.5x | 2.1x | 3.0x |
| Debt / equity | 1.9x | 1.7x | 1.3x | 1.0x | 1.6x |
| Interest coverage | 9.7x | 9.6x | 8.1x | 9.6x | 9.2x |
| Current ratio | 1.7x | 2.1x | 2.2x | 2.0x | 2.3x |
| Quick ratio | 1.7x | 2.0x | 2.1x | 1.9x | 2.3x |
| Total assets | $2.5B | $2.6B | $2.7B | $2.9B | $4.3B |
| Total liabilities | $1.9B | $1.9B | $1.8B | $1.8B | $3.0B |
| Shareholders' equity | $637M | $748M | $933M | $1.1B | $1.2B |
| Net debt (β = net cash) | $1.2B | $1.2B | $1.1B | $981M | $1.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$9.0M
4 insiders
Of sales under plans
87%
$7.8M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Rex D GevedenPresident and CEO, Director | Sold plan | 10,000 | $172.50 | $1.7M | Form 4 |
| May 12, 2026 | Rex D GevedenPresident and CEO, Director | Sold plan | 10,000 | $204.81 | $2.0M | Form 4 |
| May 11, 2026 | Michael Thomas FitzgeraldSVP & Chief Financial Officer | Sold | 2,417 | $209.25 | $0.5M | Form 4 |
| Mar 2, 2026 | Kevin James GormanVP & Chief Accounting Officer | Sold | 1,344 | $214.71 | $0.3M | Form 4 |
| Feb 25, 2026 | Gerhard F BurbachDirector | Sold | 1,983 | $208.61 | $0.4M | Form 4 |
| Feb 12, 2026 | Rex D GevedenPresident and CEO, Director | Sold plan | 10,000 | $203.26 | $2.0M | Form 4 |
| Nov 12, 2025 | Rex D GevedenPresident and CEO, Director | Sold plan | 10,000 | $197.90 | $2.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 7 / 9 | 7 / 9 |
| Accruals ratio | β4.4% | β4.5% | β4.2% |
| Altman Z'' | 5.02 | 5.16 | 4.35 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| BWX Technologies BWXT | $11.7B | 18.3% | 12.7% | 9.2% | 13.9% | 33.0x | 7 | |
| Curtiss-Wright CW | $17.2B | 12.1% | 18.1% | 15.8% | 15.9% | 32.0x | 8 | Compare β |
| Axon Enterprise AXON | $34.7B | 33.5% | β2.2% | 2.7% | β2.2% | 174.4x | 6 | Compare β |
| Moog MOG-A | $11.0B | 7.0% | 11.7% | 3.3% | 11.7% | 29.0x | 7 | Compare β |
| ATI ATI | $21.7B | 5.2% | 14.0% | 7.3% | 16.7% | 46.0x | 9 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.6B | $1.7B | $1.8B | $1.9B | $2.1B | $2.1B | $2.2B | $2.5B | $2.7B | $3.2B |
| Gross profit | $464M | $496M | $504M | $534M | $575M | $550M | $552M | $621M | $655M | $733M |
| Research and development | $6.4M | $7.2M | $15.2M | $17.7M | $14.2M | $11.1M | $9.5M | $7.6M | $7.5M | $13.9M |
| Operating income | $234M | $292M | $305M | $326M | $359M | $346M | $349M | $383M | $381M | $405M |
| Interest expense | $8.4M | $14.9M | $27.8M | $35.3M | $31.0M | $35.8M | $36.4M | $47.0M | $39.5M | $44.2M |
| Pretax income | $257M | $296M | $280M | $314M | $362M | $396M | $314M | $321M | $349M | $398M |
| Income tax | $73.7M | $147M | $52.8M | $69.1M | $83.0M | $89.4M | $75.8M | $75.1M | $66.4M | $68.3M |
| Net income | $183M | $148M | $227M | $244M | $279M | $306M | $238M | $246M | $282M | $329M |
| Diluted EPS | $1.76 | $1.47 | $2.27 | $2.55 | $2.91 | $3.24 | $2.60 | $2.68 | $3.07 | $3.58 |
| Diluted shares | 0.10B | 0.10B | 0.10B | 0.10B | 0.10B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B |
| Cash flow | ||||||||||
| Cash from operations | $240M | $222M | $169M | $279M | $196M | $386M | $245M | $364M | $408M | $480M |
| Capital expenditure | $52.6M | $96.9M | $109M | $182M | $255M | $311M | $198M | $151M | $154M | $185M |
| Free cash flow | $187M | $125M | $60.0M | $97.2M | β$58.6M | $75.0M | $46.4M | $212M | $255M | $295M |
| Depreciation and amortization | $50.6M | $56.6M | $60.1M | $61.7M | $60.7M | $69.1M | $73.8M | $78.6M | $85.9M | $109M |
| Stock-based compensation | $15.4M | $15.2M | $11.9M | $12.7M | $16.8M | $18.6M | $14.1M | $15.9M | $21.7M | $26.1M |
| Acquisitions | $118M | $0.7M | $213M | $0.0M | $15.9M | $0.0M | $47.3M | $0.0M | $0.0M | $535M |
| Share buybacks | $293M | $0.0M | $215M | $20.0M | $22.0M | $226M | $20.0M | $0.0M | $20.0M | $30.0M |
| Dividends paid | $37.4M | $42.0M | $63.8M | $65.4M | $72.9M | $79.7M | $81.1M | $85.0M | $88.3M | $92.5M |
| Dividends and buybacks | $330M | $42.0M | $279M | $85.4M | $94.9M | $305M | $101M | $85.0M | $108M | $122M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $140M | $206M | $33.5M | $92.4M | $46.3M | $37.7M | $39.0M | $75.8M | $74.1M | $500M |
| Total debt | β | $481M | $754M | $824M | $863M | $1.2B | $1.3B | $1.2B | $1.1B | $2.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $694M | $873M | $542M | $630M | $774M | $774M | $772M | $818M | $930M | $1.6B |
| Current liabilities | $440M | $528M | $377M | $405M | $530M | $460M | $368M | $375M | $474M | $672M |
| Inventory | $7.7M | $8.6M | $16.0M | $17.1M | $15.0M | $16.3M | $22.9M | $27.4M | $40.3M | $46.5M |
| Property and equipment, net | $300M | $349M | $439M | $580M | $817M | $1.0B | $1.1B | $1.2B | $1.3B | $1.6B |
| Total assets | $1.6B | $1.7B | $1.7B | $1.9B | $2.3B | $2.5B | $2.6B | $2.7B | $2.9B | $4.3B |
| Total liabilities | $1.4B | $1.4B | $1.4B | $1.5B | $1.7B | $1.9B | $1.9B | $1.8B | $1.8B | $3.0B |
| Shareholders' equity | $150M | $285M | $236M | $404M | $618M | $637M | $748M | $933M | $1.1B | $1.2B |
| Margins | ||||||||||
| Gross margin | 29.9% | 29.4% | 28.0% | 28.2% | 27.1% | 25.9% | 24.7% | 24.9% | 24.2% | 22.9% |
| Operating margin | 15.1% | 17.3% | 16.9% | 17.2% | 16.9% | 16.3% | 15.6% | 15.4% | 14.1% | 12.7% |
| EBITDA margin | 18.4% | 20.7% | 20.3% | 20.4% | 19.7% | 19.5% | 18.9% | 18.5% | 17.3% | 16.1% |
| Net margin | 11.8% | 8.8% | 12.6% | 12.9% | 13.1% | 14.4% | 10.7% | 9.9% | 10.4% | 10.3% |
| FCF margin | 12.1% | 7.4% | 3.3% | 5.1% | β2.8% | 3.5% | 2.1% | 8.5% | 9.4% | 9.2% |
| Returns | ||||||||||
| Return on capital | β | β | 32.6% | 24.3% | 21.5% | 16.6% | 14.0% | 14.4% | 14.9% | 13.9% |
| Return on capital employed | 21.7% | 25.2% | 24.8% | 23.4% | 21.9% | 18.2% | 16.2% | 16.6% | 16.0% | 13.5% |
| Return on equity | 88.1% | 67.9% | 87.1% | 76.3% | 54.5% | 48.8% | 34.4% | 29.2% | 28.0% | 28.4% |
| Return on assets | 12.4% | 9.0% | 13.5% | 13.7% | 13.3% | 12.8% | 9.3% | 9.2% | 10.0% | 9.2% |
| Growth | ||||||||||
| Revenue growth | 9.5% | 8.9% | 6.7% | 5.3% | 12.1% | 0.0% | 5.1% | 11.8% | 8.3% | 18.3% |
| Net income growth | 39.2% | β19.2% | 53.5% | 7.6% | 14.2% | 9.8% | β22.1% | 3.2% | 14.7% | 16.7% |
| EPS growth | 44.3% | β16.5% | 54.4% | 12.3% | 14.1% | 11.3% | β19.8% | 3.1% | 14.6% | 16.6% |
| FCF growth | β29.8% | β33.2% | β52.1% | 62.2% | β160.3% | β | β38.1% | 357.9% | 19.9% | 15.9% |
| Share count change | β3.5% | β3.3% | β0.4% | β4.2% | β0.1% | β1.3% | β3.0% | 0.2% | β0.0% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | 0.8x | 2.0x | 1.9x | 2.0x | 2.8x | 3.0x | 2.5x | 2.1x | 3.0x |
| Debt / equity | β | 1.7x | 3.2x | 2.0x | 1.4x | 1.9x | 1.7x | 1.3x | 1.0x | 1.6x |
| Interest coverage | 27.9x | 19.6x | 11.0x | 9.2x | 11.6x | 9.7x | 9.6x | 8.1x | 9.6x | 9.2x |
| Current ratio | 1.6x | 1.7x | 1.4x | 1.6x | 1.5x | 1.7x | 2.1x | 2.2x | 2.0x | 2.3x |
| Quick ratio | 1.6x | 1.6x | 1.4x | 1.5x | 1.4x | 1.7x | 2.0x | 2.1x | 1.9x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.4% | 5.7% | 6.1% | 9.6% | 12.0% | 14.6% | 8.9% | 6.1% | 5.7% | 5.8% |
| Stock comp / revenue | 1.0% | 0.9% | 0.7% | 0.7% | 0.8% | 0.9% | 0.6% | 0.6% | 0.8% | 0.8% |
| Payouts / FCF | 176.4% | 33.6% | 464.7% | 87.8% | β | 407.4% | 217.9% | 40.0% | 42.5% | 41.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 4.0 | 8.0 | 4.0 | 5.0 | 5.0 | 7.0 | 7.0 | 7.0 |
| Altman Z'' | 4.0 | 4.6 | 4.4 | 4.5 | 4.3 | 4.4 | 4.7 | 5.0 | 5.2 | 4.4 |
| Accruals ratio | β3.9% | β4.5% | 3.4% | β2.0% | 3.9% | β3.3% | β0.3% | β4.4% | β4.5% | β4.2% |
Source: SEC EDGAR XBRL filings (CIK 0001486957). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.